Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06353217 · ClinicalTrials.gov registry record · NA
Study of a Primary Care Hypoglycemia Prevention Program
A NA study of Diabetes Mellitus and Hypoglycemia, sponsored by Johns Hopkins University.
- Active
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT06353217: Active NA study of Diabetes Mellitus and Hypoglycemia, sponsored by Johns Hopkins University.
NCT06353217 is a NA study of Diabetes Mellitus and Hypoglycemia that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 35 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06353217, a NA study of Diabetes Mellitus and Hypoglycemia, is active but no longer recruiting, sponsored by Johns Hopkins University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single site, pre-post pilot study. The objective is to evaluate the acceptability and feasibility of a primary care hypoglycemia prevention program for patients taking hypoglycemia-causing medications. The study will also evaluate relevant process outcomes and clinical outcomes for refining the intervention and planning for a larger efficacy trial.
Primary Outcome
Mean score for overall acceptability on patient intervention evaluation survey (developed for this study, range 1-completely unacceptable, to 5-completely acceptable)
Conditions Studied
Interventions
- OTHER Patient Group (Hypoglycemia Prevention Program)
- OTHER Primary Care Physician Group
- OTHER Clinic Staff Group
Study Locations (1)
Maryland
- Johns Hopkins University School of Medicine - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2024-05-22 |
| Est. Completion | 2026-04-14 |
| Phase | NA |
What the registry record for NCT06353217 still lists
NCT06353217 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 3 interventions - of which Patient Group (Hypoglycemia Prevention Program) is the first listed.
NCT06353217 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT06353217 about?
NCT06353217 is a clinical study titled "Study of a Primary Care Hypoglycemia Prevention Program". This is a single site, pre-post pilot study. The objective is to evaluate the acceptability and feasibility of a primary care hypoglycemia prevention program for patients taking hypoglycemia-causing medications. The study will also evaluate relevant process outcomes and clinical outcomes for refinin...
What is the current status of trial NCT06353217?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2024-05-22. Estimated completion is 2026-04-14.
What conditions does trial NCT06353217 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Hypoglycemia.
What interventions are being tested in trial NCT06353217?
The interventions under investigation include: Patient Group (Hypoglycemia Prevention Program) (OTHER), Primary Care Physician Group (OTHER), Clinic Staff Group (OTHER).
Who is sponsoring clinical trial NCT06353217?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06353217 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06353217's enrollment target sits among peer trials
35 174th of 208 higher than 35 of 208 other Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI